2025Q4
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| GSK plc | 10% Owner | 13,983,761 | Jan 30, 2024 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 7, 2023 | Jan 30, 2024 | GSK plc | 10% Owner | Buy | 100.0 | +3,300,000 | 30.89% | ✗ | $16.5M |
| Jan 30, 2023 | GSK PLC | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Nov 14, 2022 | GSK PLC | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Nov 4, 2022 | GSK PLC | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Sep 16, 2022 | Sep 20, 2022 | GSK PLC | Other | Sell | 15.0 | -9,644,807 | -100.00% | ✗ | $94M |
| Jul 2, 2021 | Jul 6, 2021 | GLAXOSMITHKLINE PLC | 10% Owner | Buy | 100.0 | +275,000 | 37.54% | ✗ | $5M |
| Jul 6, 2021 | GLAXOSMITHKLINE PLC | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jun 21, 2021 | Jun 23, 2021 | GLAXOSMITHKLINE PLC | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 17, 2021 | GLAXOSMITHKLINE PLC | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| May 20, 2021 | May 24, 2021 | GLAXOSMITHKLINE PLC | 10% Owner | Sell | 15.0 | -32,005,260 | -100.00% | ✗ | $392.1M |
| Feb 17, 2021 | Feb 19, 2021 | GLAXOSMITHKLINE PLC | Director | Buy | 100.0 | +150,000 | 14.51% | ✗ | $2.7M |
| Feb 11, 2021 | GLAXOSMITHKLINE PLC | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |